{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:50:45Z","timestamp":1792795845436,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymgme.2024.108487","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:29:39Z","timestamp":1715084979000},"page":"108487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation"],"prefix":"10.1016","volume":"142","author":[{"given":"Rohit","family":"Budhraja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Radenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena J.J.","family":"Muffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulay Hicham Alaoui","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Kozicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ymgme.2024.108487_bb0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): quo vadis?","volume":"61","author":"Peanne","year":"2018","journal-title":"Eur. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10545-018-0156-5","article-title":"Recognizable phenotypes in CDG","volume":"41","author":"Ferreira","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"25","key":"10.1016\/j.ymgme.2024.108487_bb0020","doi-asserted-by":"crossref","first-page":"22498","DOI":"10.1074\/jbc.M302850200","article-title":"A new type of congenital disorders of glycosylation (CDG-ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis","volume":"278","author":"Thiel","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41390-018-0206-6","article-title":"Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls","volume":"84","author":"Asteggiano","year":"2018","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108487_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10719-021-09976-w","article-title":"Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis","volume":"38","author":"Papazoglu","year":"2021","journal-title":"Glycoconj. J."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ajmg.a.61046","article-title":"ALG11-CDG syndrome: expanding the phenotype","volume":"179","author":"Haanpaa","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108487_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41436-019-0647-2","article-title":"Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update","volume":"22","author":"Verheijen","year":"2020","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ymgme.2018.08.008","article-title":"Central nervous involvement is common in PGM1-CDG","volume":"125","author":"Radenkovic","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13023-021-01941-y","article-title":"Clinical, molecular and glycophenotype insights in SLC39A8-CDG","volume":"16","author":"Bonaventura","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0055","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41436-020-0767-8","article-title":"Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG","volume":"22","author":"Witters","year":"2020","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108487_bb0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the Pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108487_bb0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1-CDG","volume":"19","author":"Wong","year":"2017","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108487_bb0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2016-3443","article-title":"Galactose supplementation in patients with TMEM165-CDG rescues the glycosylation defects","volume":"102","author":"Morelle","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108487_bb0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI2350","article-title":"Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy","volume":"101","author":"Niehues","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm.2548","article-title":"Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice","volume":"18","author":"Schneider","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108487_bb0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1006939104442","article-title":"Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose","volume":"15","author":"Korner","year":"1998","journal-title":"Glycoconj. J."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0095","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1172\/JCI118570","article-title":"Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts","volume":"97","author":"Panneerselvam","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108487_bb0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1651-2227.1998.tb01556.x","article-title":"Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A","volume":"87","author":"Kjaergaard","year":"1998","journal-title":"Acta Paediatr."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108487_bb0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s004310050889","article-title":"Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency","volume":"157","author":"Mayatepek","year":"1998","journal-title":"Eur. J. Pediatr."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108487_bb0110","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1651-2227.1997.tb14825.x","article-title":"Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I","volume":"86","author":"Mayatepek","year":"1997","journal-title":"Acta Paediatr."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108487_bb0120","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/glycob\/cwj006","article-title":"Hydrophobic Man-1-P derivatives correct abnormal glycosylation in type I congenital disorder of glycosylation fibroblasts","volume":"15","author":"Eklund","year":"2005","journal-title":"Glycobiology"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0125","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/D1MO00132A","article-title":"Extensive heterogeneity of glycopeptides in plasma revealed by deep glycoproteomic analysis using size-exclusion chromatography","volume":"17","author":"Saraswat","year":"2021","journal-title":"Mol. Omics."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108487_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/genes14081585","article-title":"Interplay of impaired cellular bioenergetics and autophagy in PMM2-CDG","volume":"14","author":"Ligezka","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2024.108487_bb0135","first-page":"1","article-title":"AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG)","volume":"257","author":"Balakrishnan","year":"2023","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jimd.12557","article-title":"N-glycoproteomics reveals distinct glycosylation alterations in NGLY1-deficient patient-derived dermal fibroblasts","volume":"46","author":"Budhraja","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108487_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202400012","article-title":"Dysregulated proteome and N-glycoproteome in ALG1-deficient fibroblasts","author":"Budhraja","year":"2024","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108487_bb0150","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41592-021-01306-0","article-title":"Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3","volume":"18","author":"Zeng","year":"2021","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"W. Huang da, B.T. Sherman, R.A. Lempicki.","year":"2009","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0160","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.26245","article-title":"Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications","volume":"90","author":"Ligezka","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113883","article-title":"Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models","volume":"43","author":"Radenkovic","year":"2024","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.26245","article-title":"Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications","volume":"90","author":"Ligezka","year":"2021","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108487_bb0175","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/genes14081585","article-title":"Interplay of impaired cellular bioenergetics and autophagy in PMM2-CDG","volume":"14","author":"Ligezka","year":"2023","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108487_bb0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"Friesen","year":"2004","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(84)90188-0","article-title":"The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA","volume":"39","author":"Yamamoto","year":"1984","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108487_bb0190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (asp 2) as beta-secretase","volume":"14","author":"Hussain","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0021-9150(83)90184-3","article-title":"Effect of positively charged sphingomyelin liposomes on cholesterol metabolism of cells in culture","volume":"46","author":"Kudchodkar","year":"1983","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108487_bb0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jimd.12496","article-title":"Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1","volume":"45","author":"Abu Bakar","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108487_bb0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1373\/clinchem.2015.243279","article-title":"A novel N-Tetrasaccharide in patients with congenital disorders of glycosylation, including asparagine-linked glycosylation protein 1, Phosphomannomutase 2, and mannose phosphate isomerase deficiencies","volume":"62","author":"Zhang","year":"2016","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108487_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/humu.22019","article-title":"Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip","volume":"33","author":"Thiel","year":"2012","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108487_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107559","article-title":"Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation","volume":"138","author":"Tahata","year":"2023","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:38:50Z","timestamp":1716831530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224003718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1096719224003718"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108487","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108487"}}